Follow-up of patients diagnosed with germinal testicular tumors (seminomas and non-seminomatous) treated with bone marrow transplant and high dose of chemotherapy
Follow-up of patients diagnosed with germinal testicular tumors (seminomas and non-seminomatous) treated with bone marrow transplant and high dose of chemotherapy
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Show authors biography
Introducción: Germinal testicular tumors are the most common malignant neoplasm in men around 20 to 34 years. Even though they are unusual, they have increased incidence in the last decade; they have an excellent prognosis and overall survival at five years, approximately 95%. Divergent data exists regarding treatment options in patients with first, second, and third relapses with conventional therapy. Some studies describe the possible benefit of using high-dose chemotherapy associated with a bone marrow transplant with variable results
Article visits 56 | PDF visits 150
Information
